Peter Campbell
Quotient Therapeutics
UK
EMBL Conference
This conference will take place at EMBL Heidelberg, with the option to attend virtually.
Registration is not yet open for this event. If you are interested in receiving more information please register your interest.
This conference will provide an opportunity to learn about and keep up to date with the progressing area of cancer genomics.
It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer immunogenomics and epigenomics, and the translation and clinical impact of scientific results.
The meeting will bring together leading scientists and academic clinicians from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.
“The only truly international conference I know of that focuses on genomics and bioinformatics in cancer research. Offers opportunities to learn and network you just won’t get at other events.” – David Goode, Monash University, Australia
“This conference was highly relevant and provided valuable insights into cutting-edge researchin cancer genomics, AI applications, and precision medicine, with potential implications for ourongoing projects.” – Sehrish Kanwal, University of Melbourne, Australia
Quotient Therapeutics
UK
Dana-Farber Cancer Institute
USA
Brazilian National Cancer Institute
Brazil
Yale University School of Medicine
USA
Dana-Farber Cancer Institute
USA
EMBL-EBI Hinxton
UK
University Medical Center Utrecht
The Netherlands
German Cancer Research Center
Germany
University of Manchester
UK
Institute of Molecular Biology (IMB)
Germany
The Hospital for Sick Children (SickKids)
Canada
St. Anna Children’s Cancer Research Institute
Austria
CIMUS, University of Santiago de Compostela
Spain
St. Jude Children’s Research Hospital
USA
Dana-Farber Cancer Institute
USA
EMBL-EBI Hinxton
UK
University of Oxford
UK
National University of Mexico
Mexico
EMBL Heidelberg
Germany
Bronze sponsor
Media partners
Advances in Lipoprotein(a) Research, a Science Exploration Press journal
Ageing and Cancer Research & Treatment, a Science Exploration Press journal
BJC Reports, a Springer Nature journal
Cancer Drug Resistance, an OAE Publishing Inc. journal
Computational Biomedicine, a Science Exploration Press journal
Disease Models & Mechanisms, a The Company of Biologists journal
EMBO Molecular Medicine, an EMBO Press journal
EXO- Beyond the Cell, a Science Exploration Press journal
Life Sciences, an Elsevier journal
Medinformatics, a Bon View Publishing journal
Open Biology, a Royal Society journal
Sponsorship opportunities
We offer a variety of event sponsoring possibilities, with the flexibility to select a set sponsorship package or combine individual sponsorship options to suit your event budget. Discounts are available for companies sponsoring multiple events at EMBL Heidelberg. View other conferences, or contact sponsorship@embl.org for further information on sponsoring possibilities.
If you are interested in becoming a media partner of this event, please visit our media partnerships webpage.
EMBL wishes to warn sponsors of EMBL conferences and courses of fraudulent schemes purporting to offer sponsorship opportunities on behalf of EMBL or affiliated with EMBL officials. One current scam campaign of which we are aware is conducted using the name ‘Judy Eastman’ (judy@gopcontact.a2hosted.com) and entails approaches to sponsors offering sponsorship opportunities on EMBL’s behalf. Please be kindly advised that all relevant communication regarding sponsorship of EMBL conferences, symposia and courses is handled by EMBL directly and is sent from an official EMBL account. EMBL does not work with any external providers on sponsorship acquisition.
Please also note that:
Suspicious communications purportedly from, for or on behalf of EMBL should be reported to EMBL at the following email address sponsorship@embl.de.
Date: 9 - 12 Nov 2027
Location: EMBL Heidelberg and Virtual
Venue: EMBL Advanced Training Centre
Organisers:
Contact: EMBL Events
empty